NASDAQ : NGNE

Neurogene Inc.

$39.45 USD

$0.37 (0.95%)

Volume
181.59K
Average Volume
210.95K
Market Capitalization
$623.4M
P/E Ratio
-7.84
Dividend Yield
0.00%
Price Target
$70.00
Year High
$43.66
Year Low
$15.93
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$13.08
Analyst Rating

Sell

2 Rating Score

UPSIDE/DOWNSIDE

-43.6% DOWNSIDE

$70.00 Price Target

UPSIDE/DOWNSIDE HIGH

-43.6% DOWNSIDE

$70.00 Price Target High

UPSIDE/DOWNSIDE LOW

-42.8% DOWNSIDE

$69.00 Price Target Low

NGNE Upgrades Downgrades Consensus

Overall Consensus: Buy  |  Total Analysts: 6

Strong Buy Buy Hold Sell Strong Sell
0 5 1 0 0
Analyst Company Analyst Name Price Target Price When Posted Date Upside/Downside
H.C. Wainwright Mitchel Kapoor $70 $28.6 2026-06-09 06:47 AM 144.8%
BMO Capital Keith Tapper $16 $10.89 2025-04-14 07:53 AM 46.9%
Robert W. Baird Joel Beatty $38 $14.2 2025-03-25 07:01 AM 167.6%
H.C. Wainwright Mitchell Kapoor $50 $14.2 2025-03-25 06:32 AM 252.1%
Stifel Nicolaus Paul Matteis $46 $15.33 2024-11-20 04:53 PM 200.1%
BMO Capital Keith Tapper $45 $35.59 2024-11-19 04:02 PM 26.4%
BMO Capital Keith Tapper $60 $64.48 2024-11-12 09:09 AM -6.9%